dacarbazine has been researched along with Astroblastoma in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (48.00) | 29.6817 |
2010's | 13 (52.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alattar, AA; Ali, MA; Brandel, MG; Carroll, KT; Carter, B; Chen, CC; Hirshman, B; Lanman, T; Lochte, B | 1 |
Gao, Z; Lai, X; Mao, G; Xiao, X; Zhang, J; Zhu, J; Zhu, X | 1 |
Braca, J; Kovanda, T; Prabhu, V | 1 |
Ohta, H; Sato, Y; Takeshima, H; Uehara, H; Yamasaki, K; Yamashita, S; Yokogami, K | 1 |
Bertero, L; Cassoni, P; Rudà, R | 1 |
Chen, Z; Lai, X; Song, S; Zhu, J; Zhu, X | 1 |
Fenstermaker, RA; Mechtler, LL; Morr, S; Prasad, D; Qiu, J | 1 |
Aksamit, AJ; Clarke, MJ; Giannini, C; Glantz, J; Jicha, GA; Kumar, N; Lehwald, LM; Russo, DP; Uhm, J; Wald, JT; Wetmore, CJ | 1 |
Brockmann, MA; Hermes, P; Kohlhof, P; Neumaier-Probst, E; Schmieder, K; Seiz, M; Tuettenberg, J; Vajkoczy, P; VON Deimling, A | 1 |
Kim, JH; Kim, ST; Kim, WS; Kong, DS; Kwon, KH; Lee, JI; Lim, DH; Nam, DH; Park, K; Suh, YL | 1 |
Berg, A; Kolesar, J; Mehta, M; Petrich, RJ; Steen, P; Sylvester, RK; Tate, JM | 1 |
Inoue, T; Kanamori, M; Kumabe, T; Sonoda, Y; Tominaga, T; Watanabe, M | 1 |
Ara, J; Chadarévian, JP; Faerber, EN; Grant, ML; Halligan, GE; Katsetos, CD; Legido, A; Morrissette, JD; Piatt, JH | 1 |
Gizewski, ER; Hansen, N; Hense, J; Kastrup, O; Van de Nes, JA; Wittig, A | 1 |
Adamson, DC; Lark, AL; Mattox, AK | 1 |
Baruchel, S; Becker, L; Bouffet, E; Gammon, J; Hargrave, D; Rutka, J | 1 |
Ambrosetto, P; Barbiroli, B; Cortelli, P; Crinò, L; Franceschi, E; Lodi, R; Setola, E; Tonon, C | 1 |
Chamberlain, MC | 1 |
Carpentier, A; Cartalat-Carel, S; Chinot, O; Cougnard, J; Delattre, JY; Djafari, L; Duffau, H; Gervais, H; Hoang-Xuan, K; Honnorat, J; Laigle, F; Mokhtari, K; Napolitano, M; Sanson, M; Taillandier, L; Taillibert, S | 1 |
Gomori, JM; Levin, N; Siegal, T | 1 |
Landi, A; Piccirilli, M; Salvati, M | 1 |
Bouffet, E; Fukushima, S; Katsuki, H; Shigemori, M; Terasaki, M | 1 |
El-Koussy, M; Fathi, AR; Kappeler, A; Mariani, L; Novoa, E; Vajtai, I | 1 |
Delattre, JY; Ducray, F; Everhard, S; Hoang-Xuan, K; Idbaih, A; Kaloshi, G; Laigle-Donadey, F; Marie, Y; Mokhtari, K; Navarro, S; Sanson, M; Thillet, J | 1 |
Benjelloun, A; Delavelle, J; Dietrich, PY; Lazeyras, F | 1 |
2 review(s) available for dacarbazine and Astroblastoma
Article | Year |
---|---|
Cerebellar gliomatosis in a toddler: case report of a challenging condition and review of the literature.
Topics: Antineoplastic Agents, Alkylating; Cerebellar Neoplasms; Cerebellum; Child, Preschool; Dacarbazine; Humans; Intermediate Filament Proteins; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Nerve Tissue Proteins; Nestin; Neurosurgery; Oligodendroglia; Oligodendroglioma; Receptor, Platelet-Derived Growth Factor alpha; Temozolomide; Tumor Cells, Cultured; Vimentin | 2012 |
Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; DNA Methylation; Female; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Temozolomide; Treatment Outcome; Young Adult | 2012 |
5 trial(s) available for dacarbazine and Astroblastoma
Article | Year |
---|---|
Impact of adjuvant chemotherapy for gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Chemotherapy, Adjuvant; Child; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Female; Humans; Lomustine; Male; Middle Aged; Neoplasm Staging; Neoplasms, Neuroepithelial; Neoplasms, Radiation-Induced; Procarbazine; Prognosis; Retrospective Studies; Survival Rate; Temozolomide; Vincristine; Young Adult | 2010 |
Initial chemotherapy in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Hematologic Diseases; Humans; Karnofsky Performance Status; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Procarbazine; Survival Analysis; Temozolomide; Treatment Outcome; Vincristine | 2004 |
Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Disease-Free Survival; Female; Glioblastoma; Humans; Life Tables; Male; Middle Aged; Neoplasms, Neuroepithelial; Oligodendroglioma; Prospective Studies; Temozolomide; Treatment Outcome | 2004 |
Pilot trial of the rate of response, safety, and tolerability of temozolomide and oral VP-16 in patients with recurrent or treatment-induced malignant central nervous system tumors.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Dacarbazine; Drug Therapy, Combination; Etoposide; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Neoplasms, Second Primary; Pilot Projects; Temozolomide; Treatment Outcome | 2008 |
Genetic markers predictive of chemosensitivity and outcome in gliomatosis cerebri.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Biomarkers, Tumor; Chromosome Mapping; Chromosomes, Human, Pair 19; Cohort Studies; Dacarbazine; Disease-Free Survival; DNA Mutational Analysis; Female; Genetic Markers; Humans; Male; Middle Aged; Neoplasms, Neuroepithelial; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Retrospective Studies; Temozolomide | 2008 |
18 other study(ies) available for dacarbazine and Astroblastoma
Article | Year |
---|---|
Management and Survival Patterns of Patients with Gliomatosis Cerebri: A SEER-Based Analysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Cranial Irradiation; Dacarbazine; Disease Management; Female; Glioblastoma; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasms, Multiple Primary; Neoplasms, Neuroepithelial; Neurosurgical Procedures; Oligodendroglioma; Proportional Hazards Models; Retrospective Studies; SEER Program; Survival Rate; Temozolomide | 2017 |
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cell Line, Tumor; Dacarbazine; Drug Carriers; Drug Delivery Systems; Drug Liberation; Humans; Lactoferrin; Lipids; Mice, Inbred BALB C; Nanostructures; Neoplasms, Neuroepithelial; Oligopeptides; Temozolomide; Tissue Distribution; Vincristine; Xenograft Model Antitumor Assays | 2018 |
Bilateral ptosis as initial presentation of gliomatosis cerebri: case report.
Topics: Anticonvulsants; Antineoplastic Agents, Alkylating; Blepharoptosis; Brain Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Dacarbazine; Diagnosis, Differential; Diplopia; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Neurosurgical Procedures; Seizures; Temozolomide; Young Adult | 2013 |
Case of primary diffuse leptomeningeal gliomatosis.
Topics: Antineoplastic Agents, Alkylating; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; Fatal Outcome; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Methylation; Middle Aged; Neoplasms, Neuroepithelial; Promoter Regions, Genetic; Radiotherapy; Temozolomide; Tumor Suppressor Proteins | 2014 |
Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain; Brain Abscess; Brain Neoplasms; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Nocardia Infections; Temozolomide | 2015 |
Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Chemistry, Pharmaceutical; Dacarbazine; DNA; Drug Carriers; Drug Delivery Systems; Humans; Lipids; Mice; Nanomedicine; Nanostructures; Neoplasms, Neuroepithelial; Temozolomide; Transfection | 2016 |
Radiologic response to radiation therapy concurrent with temozolomide for progressive simple dysembryoplastic neuroepithelial tumor.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Glioma; Humans; Neoplasms, Neuroepithelial; Temozolomide | 2016 |
Primary diffuse leptomeningeal gliomatosis.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain; Dacarbazine; Diagnosis, Differential; Humans; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Meninges; Meningitis; Neoplasms, Neuroepithelial; Perfusion Imaging; Spinal Cord; Temozolomide; Treatment Outcome; Young Adult | 2009 |
First experiences with low-dose anti-angiogenic treatment in gliomatosis cerebri with signs of angiogenic activity.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Celecoxib; Cell Proliferation; Cyclooxygenase 2; Dacarbazine; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Immunoenzyme Techniques; Male; Middle Aged; Neoplasm Staging; Neoplasms, Neuroepithelial; Neovascularization, Pathologic; Prognosis; Pyrazoles; Sulfonamides; Survival Rate; Temozolomide; Vascular Endothelial Growth Factor A | 2009 |
Temozolomide-induced severe myelosuppression: analysis of clinically associated polymorphisms in two patients.
Topics: Adult; Antineoplastic Agents, Alkylating; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Dacarbazine; Female; Glioma; Glutathione S-Transferase pi; Humans; Male; Middle Aged; Myeloproliferative Disorders; NAD(P)H Dehydrogenase (Quinone); Neoplasms, Neuroepithelial; O(6)-Methylguanine-DNA Methyltransferase; Patients; Polymorphism, Single Nucleotide; Promoter Regions, Genetic; Temozolomide | 2011 |
Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Biopsy; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Fatal Outcome; Female; Humans; Immunohistochemistry; Kaplan-Meier Estimate; Ki-67 Antigen; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasms, Neuroepithelial; Neurosurgical Procedures; Nimustine; O(6)-Methylguanine-DNA Methyltransferase; Prognosis; Retrospective Studies; Temozolomide; Tumor Suppressor Protein p53; Young Adult | 2010 |
Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.
Topics: Antineoplastic Agents, Alkylating; Chemoradiotherapy; Dacarbazine; Humans; Male; Meningeal Neoplasms; Middle Aged; Neoplasms, Neuroepithelial; Survival Rate; Temozolomide; Treatment Outcome | 2011 |
Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Brain Neoplasms; Dacarbazine; Female; Humans; Leukemia, B-Cell; Magnetic Resonance Imaging; Neoplasms, Neuroepithelial; Neoplasms, Radiation-Induced; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Temozolomide; Treatment Outcome | 2003 |
Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
Topics: Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasms, Neuroepithelial; Temozolomide; Treatment Outcome | 2003 |
Gliomatosis cerebri: better definition, better treatment.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Astrocytes; Astrocytoma; Brain; Brain Neoplasms; Cell Cycle Proteins; Dacarbazine; Disease Progression; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Neuroepithelial; Nerve Tissue Proteins; Procarbazine; Temozolomide; Vincristine | 2004 |
Gliomatosis cerebri treatment in 11 elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Progression; Female; Humans; Lomustine; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Procarbazine; Survival Rate; Temozolomide | 2006 |
Astroblastoma with rhabdoid features and favorable long-term outcome: report of a case with a 12-year follow-up.
Topics: Antibodies, Antinuclear; Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Brain Neoplasms; Cell Differentiation; Cerebral Angiography; Chemotherapy, Adjuvant; Craniotomy; Dacarbazine; Glial Fibrillary Acidic Protein; Humans; Ki-67 Antigen; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Neuroepithelial; Parietal Lobe; Radiotherapy, Adjuvant; Reoperation; Rhabdoid Tumor; Temozolomide; Time Factors; Treatment Outcome; Vimentin | 2008 |
Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Topics: Adult; Antineoplastic Agents, Alkylating; Brain; Brain Neoplasms; Dacarbazine; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Neuroepithelial; Temozolomide; Treatment Outcome | 2001 |